SEC Form 4 · accession 0001209191-19-017379
Kezar Life Sciences, Inc. · KZR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vassiliki Economides
Officer — SVP, Strategy & External Aff.
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645666
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $20.25 | Mar 4, 2019 | A | 70,000 | A | — | Mar 3, 2029 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on March 4, 2019, subject to the Reporting Person continuing to provide service through each such date.